EDGAR Filing Documents for 0001157523-17-001455

Form 8-K - Current report:

SEC Accession No. 0001157523-17-001455

Filing Date

2017-05-05

Accepted

2017-05-05 08:10:20

Documents

Period of Report

2017-05-02

Items

Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	ALNYLAM PHARMACEUTICALS, INC. 8-K	a51553442.htm	8-K	39776
2	EXHIBIT 99.1	a51553442ex99_1.htm	EX-99.1	64111
	Complete submission text file	0001157523-17-001455.txt		105123

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142

Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200

ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36407 | Film No.: 17816160
SIC: 2834 Pharmaceutical Preparations